Lupin receives tentative approval for Apixaban Tablets Lupin receives tentative approval for Apixaban Tablets DSIJ Intelligence / Monday, December 10, 2018 0 2429 Article rating: 3.5 Lupin has received tentative approval from USFDA to market Apixaban Tablets, 2.5 mg and 5 mg. The tablet is indicated to treat several ailments including reducing the risk of stroke and systemic embolism. Read more
Tata Motors Group posts 7 per cent decline in global wholesales Tata Motors Group posts 7 per cent decline in global wholesales DSIJ Intelligence / Monday, December 10, 2018 0 1255 Article rating: 4.0 Tata Motors Group's global wholesales for the month was at 1,04,964 units in November, lower by 7 per cent on a YoY basis. This include Tata Motors passenger vehicles, Tata Motors commercial vehicles and Jaguar Land Rover. Read more
Ten stocks close to their 52-week low Ten stocks close to their 52-week low Shital Jibhe / Monday, December 10, 2018 0 1243 Article rating: 3.0 Following stocks are close to their 52-week low as at 2.54 p.m. on December 10, 2018. Read more
Ten stocks close to their 52-week high Ten stocks close to their 52-week high Shital Jibhe / Monday, December 10, 2018 0 976 Article rating: 5.0 The markets on December 10, 2018 opened gap down. BSE Sensex is trading at 35,033.70, down by 639.55 points and the Nifty is trading at 10,497.35, down by 196.35 points. Read more
Alembic Pharma gets USFDA approval for Ophthalmic Solution Alembic Pharma gets USFDA approval for Ophthalmic Solution DSIJ Intelligence / Monday, December 10, 2018 0 1310 Article rating: 5.0 Pharma major Alembic Pharmaceuticals received approval from the USFDA for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.1%. The stocks gained around 2 per cent intraday post the news. Read more